MARKET

CLYM

CLYM

Climb Bio
NASDAQ
1.950
0.000
0.00%
After Hours: 1.980 +0.03 +1.54% 19:59 12/20 EST
OPEN
1.930
PREV CLOSE
1.950
HIGH
2.065
LOW
1.860
VOLUME
1.47M
TURNOVER
--
52 WEEK HIGH
11.55
52 WEEK LOW
1.860
MARKET CAP
131.09M
P/E (TTM)
-0.9134
1D
5D
1M
3M
1Y
5Y
1D
Climb Bio, Inc. to Join NASDAQ Biotechnology Index Effective December 23, 2024
Barchart · 2d ago
Climb Bio set to join Nasdaq Biotech Index
Seeking Alpha · 2d ago
CLIMB BIO INC - INCLUSION IN NASDAQ BIOTECH INDEX EFFECTIVE PRIOR TO MARKET OPEN ON DECEMBER 23, 2024
Reuters · 2d ago
CLIMB BIO TO BE ADDED TO THE NASDAQ BIOTECHNOLOGY INDEX
Reuters · 2d ago
Weekly Report: what happened at CLYM last week (1209-1213)?
Weekly Report · 5d ago
Weekly Report: what happened at CLYM last week (1202-1206)?
Weekly Report · 12/09 10:14
CLIMB BIO INC <CLYM.O>: LEERINK PARTNERS INITIATES COVERAGE WITH OUTPERFORM RATING; PRICE TARGET $10
Reuters · 12/02 11:21
Weekly Report: what happened at CLYM last week (1125-1129)?
Weekly Report · 12/02 10:14
More
About CLYM
Climb Bio, Inc., formerly Eliem Therapeutics, Inc., is a clinical-stage biotechnology company. The Company is focused on developing therapeutics for patients with immune-mediated diseases. The Company’s lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody designed to deplete CD19-positive B cells, including antibody-secreting cells, in order to directly reduce pathogenic autoantibodies. The reduction of autoantibodies has the potential to be disease-modifying in autoantibody-driven diseases, such as systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy. The budoprutug is in Phase I clinical trial.

Webull offers Climb Bio Inc stock information, including NASDAQ: CLYM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLYM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLYM stock methods without spending real money on the virtual paper trading platform.